Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-07-21

Clinical Trial Update: Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract [NA]

View source ↗

Summary

A multicenter trial evaluating intravenous immunoglobulin in combination with antibacterial agents for surgical site infection of the lower digestive tract has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group | Conditions: Peritonitis, Postoperative Complications | NA | Status: WITHDRAWN